Misplaced Pages

Steroid 21-hydroxylase
Identifiers
EC no.	1.14.14.16
CAS no.	9029-68-9
Alt. names	"Cytochrome P450, family 21, subfamily A, polypeptide 2", CYP21A2, CYP21, CYP21B, P45021A2, cytochrome P450c21, steroid 21-monooxygenase, 21-hydroxylase, 21α-hydroxylase, 21β-hydroxylase
Databases
IntEnz	IntEnz view
BRENDA	BRENDA entry
ExPASy	NiceZyme view
KEGG	KEGG entry
MetaCyc	metabolic pathway
PRIAM	profile
PDB structures	RCSB PDB PDBe PDBsum
Gene Ontology	AmiGO / QuickGO
Search PMC articles PubMed articles NCBI proteins

Steroid 21-hydroxylase is a protein that in humans is encoded by the CYP21A2 gene. The protein is an enzyme that hydroxylates steroids at the C21 position on the molecule. Naming conventions for enzymes are based on the substrate acted upon and the chemical process performed. Biochemically, this enzyme is involved in the biosynthesis of the adrenal gland hormones aldosterone and cortisol, which are important in blood pressure regulation, sodium homeostasis and blood sugar control. The enzyme converts progesterone and 17α-hydroxyprogesterone into 11-deoxycorticosterone and 11-deoxycortisol, respectively, within metabolic pathways which in humans ultimately lead to aldosterone and cortisol creation—deficiency in the enzyme may cause congenital adrenal hyperplasia.

Steroid 21-hydroxylase is a member of the cytochrome P450 family of monooxygenase enzymes that use an iron-containing heme cofactor to oxidize substrates.

In humans, the enzyme is localized in endoplasmic reticulum membranes of cells in adrenal cortex, and is encoded by the CYP21A2 gene which is located near the CYP21A1P pseudogene that has high degree of sequence similarity. This similarity makes it difficult to analyze the gene at the molecular level, and sometimes leads to loss-of-function mutations of the gene due to intergenic exchange of DNA.

Gene

CYP21A2
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 4Y8W,%%s2GEG
Identifiers
Aliases	CYP21A2, CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B, cytochrome P450 family 21 subfamily A member 2
External IDs	OMIM: 613815; MGI: 88591; HomoloGene: 68063; GeneCards: CYP21A2; OMA:CYP21A2 - orthologs
EC number	1.14.14.16,1.14.14.16
Gene location (Human) Chr. Chromosome 6 (human) Band 6p21.33 Start 32,038,265 bp End 32,041,670 bp
Gene location (Mouse) Chr. Chromosome 17 (mouse) Band 17 B1|17 18.36 cM Start 35,020,322 bp End 35,023,535 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in right adrenal gland left adrenal gland right adrenal cortex left adrenal cortex right lobe of liver testicle left ovary spleen right ovary gastric mucosa Top expressed in adrenal gland spermatid spermatocyte Gonadal ridge gastrula muscle of thigh cervix hepatobiliary system liver spleen More reference expression data BioGPS More reference expression data
Gene ontology Molecular function iron ion binding metal ion binding monooxygenase activity steroid hydroxylase activity steroid binding heme binding oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen oxidoreductase activity lipid binding steroid 21-monooxygenase activity Cellular component organelle membrane endoplasmic reticulum membrane membrane intracellular membrane-bounded organelle endoplasmic reticulum Biological process glucocorticoid biosynthetic process mineralocorticoid biosynthetic process sterol metabolic process steroid biosynthetic process steroid metabolic process Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 1589 13079 Ensembl ENSG00000198457 ENSG00000231852 ENSG00000206338 ENSG00000233151 ENSG00000232414 ENSG00000235134 ENSMUSG00000024365 UniProt P08686 Q08AG9 P03940 RefSeq (mRNA) NM_000500 NM_001128590 NM_009995 RefSeq (protein) NP_000491 NP_001122062 NP_001355072 NP_001355073 NP_000491.4 NP_001122062.3 NP_034125 Location (UCSC) Chr 6: 32.04 – 32.04 Mb Chr 17: 35.02 – 35.02 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Steroid 21-hydroxylase in humans is encoded by the CYP21A2 gene that may be accompanied by one or several copies of the nonfunctional pseudogene CYP21A1P, this pseudogene shares 98% of the exonic informational identity with the actual functional gene.

Pseudogenes are common in genomes, and they originate as artifacts during the duplication process. Though often thought of as "junk DNA", research has shown that retaining these faulty copies can have a beneficial role, often providing regulation of their parent genes.

In the mouse genome, the Cyp21a2 is a pseudogene and the Cyp21a1 is a functional gene. In the chicken and quail, there is only a single Cyp21 gene, which locus is located between complement component C4 and TNX gene, along with Cenpa.

CYP21A2 in humans is located in chromosome 6, in the major histocompatibility complex III (MHC class III) close to the Complement component 4 genes C4A and C4B, the Tenascin X gene TNXB and STK19. MHC class III is the most gene-dense region of the human genome, containing many genes that have, as of 2023 - unknown functions or structures.

Inside the MHC class III, CYP21A2 is located within the RCCX cluster (an abbreviation composed of the names of the genes RP (a former name for STK19 serine/threonine kinase 19), C4, CYP21 and TNX), which is the most complex gene cluster in the human genome. The number of RCCX segments varies between one and four in a chromosome, with the prevalence of approximately 15% for monomodular, 75% for bimodular (STK19-C4A-CYP21A1P-TNXA-STK19B-C4B-CYP21A2-TNXB), and 10% for trimodular in Europeans. The quadrimodular structure of the RCCX unit is very rare. In a monomodular structure, all of the genes are functional i.e. protein-coding, but if a module count is two or more, there is only one copy of each functional gene rest being non-coding pseudogenes with the exception of the C4 gene which always has active copies.

Due to the high degree of homology between the CYP21A2 gene and the CYP21A1P pseudogene and the complexity of the RCCX locus, it is difficult to perform molecular diagnostics for CYP21A2. The pseudogene can have single-nucleotide polymorphisms (SNP) that are identical or similar to those in the functional gene, making it difficult to distinguish between them. The pseudogene can also recombine with the functional gene, creating hybrid genes that have features of both. This can result in false-positive or false-negative results when testing for SNPs in the CYP21A2.

The whole genome sequencing technology relies on breaking the DNA into small fragments, sequencing them, and then assembling them back together based on their overlaps. However, because of the high homology and variability of the CYP21A2 and its pseudogene, the fragments cannot be mapped unambiguously to either copy of the gene. This can lead to errors or gaps in the assembly, or missing some variants that are present in the gene.

Polymerase chain reaction (PCR) molecular diagnostics uses selective primers to amplify specific segments of the DNA sequence that are relevant for diagnosing or detecting a certain disease or condition. If the primers are not designed carefully, they may bind to both the CYP21A2 and the CYP21A1P pseudogene, or to different segments of the RCCX cluster, resulting in false-positive or false-negative results. Therefore, PCR for the CYP21A2 requires the use of locus-specific primers that can distinguish between the gene and the pseudogene, and between different RCCX modules. Moreover, PCR may not be able to detect complex variants such as large gene conversions, deletions, or duplications, which are frequent in the case of the CYP21A2.

Southern blotting, a method used for detecting and quantifying a specific DNA sequence in DNA samples, also has limitations in analyzing CYP21A2. This method is time-consuming and requires a large amount of good-quality DNA, which makes it less applicable in routine diagnostic settings. This method comes with a radioactive biohazard, which poses safety concerns and makes it labor-intensive. Southern blotting is unable to detect the junction sites of chimeras. The CYP21A2 gene is prone to mismatch and rearrangement, producing different types of complex variations that include copy number variants, large gene conversions, small insertions/deletions, and single-nucleotide (SNP) variants. Southern blotting is not capable of detecting all these types of variants simultaneously. Besides that, southern blotting requires genetic analysis of the parents, which is not always feasible or practical.

Therefore, to analyze the CYP21A2 gene accurately, a more specialized and sensitive method is needed, such as targeted long-read sequencing, which can sequence longer DNA fragments and capture more information about the gene structure and variation. However, this method is not widely available or affordable for clinical use.

Protein

Steroid 21-hydroxylase, is a member of the cytochrome P450 family of monooxygenase enzymes, the protein has 494 amino acid residues with a molecular weight of 55,000. This enzyme is at most 28% homologous to other P-450 enzymes that have been studied.

Structurally, the protein contains an evolutionarily conserved core of four α-helix bundles (the importance of such genetic conservation is in demonstrating the functional importance of this aspect of this protein's structure). In addition, it has two additional alpha helices, two sets of β-sheets, and a heme cofactor binding loop. Each subunit in the human enzyme consists of a total of 13 α-helices and 9 β-strands that folds into a triangular prism-like tertiary structure.

The iron(III) heme group that defines the active site resides in the center of each subunit. The human enzyme binds one substrate at a time. In contrast, the well-characterized bovine enzyme can bind two substrates. The human and bovine enzyme share 80% amino acid sequence identity, but are structurally different, particularly in loop regions, and also evident in secondary structure elements.

Species

Variations of the steroid 21-hydroxylase can be found in all vertebrates.

Cyp21 first emerged in chordates before the speciation between basal chordates and vertebrates. The sea lamprey, an early jawless fish species that originated over 500 million years ago, provides valuable insights into the evolution and emergence of Cyp21. Sea lampreys lack the 11β-hydroxylase enzyme responsible for converting 11-deoxycortisol to cortisol as observed in mammals. Instead, they rely on 11-deoxycortisol, a product of a reaction catalyzed by CYP21, as their primary glucocorticoid hormone with mineralocorticoid properties. This suggests the presence of a complex and highly specific corticosteroid signaling pathway that emerged at least half a billion years ago during early vertebrate evolution.

In vertebrates, such as fish, amphibians, reptiles, birds, and mammals, Cyp21 participates in the biosynthesis of glucocorticoids and mineralocorticoids, therefore, Cyp21 is essential for the regulation of stress response, electrolyte balance and blood pressure, immune system, and metabolism in vertebrates.

Cyp21 is relatively conserved among mammals, and shows some variations in its structure, expression, and regulation. Rhesus macaques and orangutans possess two copies of Cyp21, while chimpanzees have three, still, a pseudogene (CYP21A1P) is only present in humans among primates.

Tissue and subcellular distribution

Steroid 21-hydroxylase is localized in microsomes of endoplasmic reticulum membranes within adrenal cortex. It is one of three microsomal steroidogenic cytochrome P450 enzymes, the others being steroid 17-hydroxylase and aromatase.

Unlike other enzymes of the cytochrome P450 superfamily of enzymes that are expressed in multiple tissues, with most abundant expression in the liver, in adult humans steroid 21-hydroxylase, along with steroid 11β-hydroxylase and aldosterone synthase, is almost exclusively expressed in the adrenal gland.

As of 2023, the main subcellular location for the encoded protein in human cells is not known, and is pending cell analysis.

Function

The enzyme, steroid 21-hydroxylase hydroxylates steroids at the C21 position. Steroids are a group of naturally occurring and synthetically produced organic compounds, steroids all share a four ring primary structure. The enzyme catalyzes the chemical reaction in which the hydroxyl group (-OH) is added at the C21 position of the steroid biomolecule. This location is on a side chain of the D ring.

The enzyme is a member of the cytochrome P450 superfamily of monooxygenase enzymes. The cytochrome P450 enzymes catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids.

Steroid 21-hydroxylase is essential for the biosynthesis of cortisol and aldosterone.

Mechanism

Steroid 21-hydroxylase is a cytochrome P450 enzyme that is notable for its substrate specificity and relatively high catalytic efficiency.

Like other cytochrome P450 enzymes, steroid 21-hydroxylase participates in the cytochrome P450 catalytic cycle and engages in one-electron transfer with NADPH-P450 reductase. Steroid 21-hydroxylase is highly specific for hydroxylation of progesterone and 17-hydroxyprogesterone. This is in marked contrast to the evolutionarily and functionally related P450 enzyme 17-hydroxylase, which has a broad range of substrates.

The chemical reaction in which steroid 21-hydroxylase catalyzes the addition of hydroxyl (-OH) to the C21 position of progesterone, 17α-hydroxyprogesterone and 21-desoxycortisone was first described in 1952.

Studies of the human enzyme expressed in yeast initially classified 17-hydroxyprogesterone as the preferred substrate for steroid 21-hydroxylase, however, later analysis of the purified human enzyme found a lower K_M and greater catalytic efficiency for progesterone over 17-hydroxyprogesterone.

The catalytic efficiency of steroid 21-hydroxylase for conversion of progesterone in humans is approximately 1.3 x 10 Ms at 37 °C. This makes it the most catalytically efficient P450 enzyme of those reported to date, and catalytically more efficient than the closely related bovine steroid 21-hydroxylase enzyme. C-H bond breaking to create a primary carbon radical is thought to be the rate-limiting step in the hydroxylation.

Clinical significance

Congenital adrenal hyperplasia

Genetic variants in the CYP21A2 gene cause a disturbance in the development of the enzyme, leading to congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Gene conversion events involving the functional gene and the pseudogene account for many cases of steroid 21-hydroxylase deficiency. CAH is an autosomal recessive disorder. There are multiple forms of CAH, defined as classical and nonclassical forms based on the amount of enzyme function still present in the patient.

The classical forms occur in approximately 1 in 10000 to 1 in 20000 births globally, and includes both the salt-wasting (excessive excretion of sodium via the urine causing hyponatremia and dehydration) and simple-virilizing forms. Complete loss of enzymatic activity causes the salt-wasting form. Variations in the structure of steroid 21-hydroxylase are related to the clinical severity of congenital adrenal hyperplasia. Cortisol and aldosterone deficits are associated with life-threatening sodium loss, as the steroids play roles in regulating sodium homeostasis. Simple-virilizing CAH patients (~1-2% enzyme function) maintain adequate sodium homeostasis, but exhibit other symptoms shared by the salt-wasting form, including accelerated growth in childhood and ambiguous genitalia in female neonates.

The nonclassical form is the mildest condition, retaining about 20% to 50% of enzyme function. This form is associated with mild and clinically silent cortisol impairment, but an excess of androgens post-puberty.

Non-classic congenital adrenal hyperplasia

Non-classical congenital adrenal hyperplasia caused by 21-hydroxylase deficiency (NCCAH) is a milder and late-onset congenital adrenal hyperplasia. Its prevalence rate in different ethnic groups varies from 1 in 1000 to 1 in 50. Some people affected by the condition have no relevant signs and symptoms, while others experience symptoms of hyperandrogenism.

Women with NCCAH usually have normal female genitalia at birth. In later life, the signs and symptoms of the condition may include acne, hirsutism, male-pattern baldness, irregular menstruation, and infertility.

Fewer studies have been published about males with NCCAH comparing to those about females, because males are generally asymptomatic. Males, however, may present with acne and early balding.

While symptoms are usually diagnosed after puberty, children may present with premature adrenarche.

Research on other conditions

There is ongoing research on how Genetic variants in the CYP21A2 gene may lead to pathogenic conditions. A variant of this gene has been reported to cause autosomal dominant posterior polar cataract, suggesting that steroid 21-hydroxylase may be involved in the extra-adrenal biosynthesis of aldosterone and cortisol in the lens of the eye.

History

In the 1950s and 1960s, steroidogenic pathways that included cholesterol conversion to progesterone through a complex pathway involving multiple steps were identified, and, among them, a pathway for cortisol synthesis showing specific enzymatic steps that included hydroxylation reactions at position 21 (21-hydroxylation) mediated by cytochrome P450 enzymes. Cytochrome P450 enzymes were then described, and steroid 21-hydroxylation was associated with cytochrome P450.

In the 1980s and 1990s, partial-length bovine Cyp21 cDNA clones were identified as related to human CYP21A2. Researchers discovered mutations in the CYP21A2 gene associated with congenital adrenal hyperplasia (CAH).

From the 1990s onward, specific mutations were correlated with different forms/severity levels of CAH. Genotype/phenotype correlations were investigated for improved diagnostic accuracy.

See also

• Steroidogenic enzyme
• Cytochrome P450 oxidoreductase deficiency

References

1. "UniProt". www.uniprot.org. Archived from the original on 28 November 2023. Retrieved 26 November 2023.
2. Marino S, Perez Garrido N, Ramírez P, Pujana M, Dratler G, Belgorosky A, Marino R (2020). "Molecular analysis of the CYP21A2 gene in dried blood spot samples". Medicina. 80 (3): 197–202. PMID 32442933.
3. Kaewkot A, Boonkaewwan C, Noosud J, Kayan A (November 2017). "Expression level of the cytochrome P450c21 (CYP21) protein correlating to drip loss in pigs". Animal Science Journal. 88 (11): 1855–1859. doi:10.1111/asj.12863. PMID 28677294.
4. Mizrachi D, Wang Z, Sharma KK, Gupta MK, Xu K, Dwyer CR, Auchus RJ (May 2011). "Why human cytochrome P450c21 is a progesterone 21-hydroxylase". Biochemistry. 50 (19): 3968–74. doi:10.1021/bi102078e. PMC 3165045. PMID 21446712.
5. "Information on EC 1.14.14.16 - steroid 21-monooxygenase - BRENDA Enzyme Database". www.brenda-enzymes.org. Archived from the original on 11 October 2020. Retrieved 21 September 2020.
6. Mukangwa M, Takizawa K, Aoki Y, Hamano S, Tetsuka M (February 2020). "Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum". The Journal of Reproduction and Development. 66 (1): 75–81. doi:10.1262/jrd.2019-127. PMC 7040213. PMID 31839646.
7. Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK (July 2012). "Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening". Clinical Genetics. 82 (1): 64–70. doi:10.1111/j.1399-0004.2011.01694.x. PMID 21534945. S2CID 7197547.
8. Bergamaschi R, Livieri C, Uggetti C, Candeloro E, Egitto MG, Pichiecchio A, Cosi V, Bastianello S (March 2006). "Brain white matter impairment in congenital adrenal hyperplasia". Archives of Neurology. 63 (3): 413–6. doi:10.1001/archneur.63.3.413. PMID 16540460.
9. Marcol W, Kalina-Faska B, Wackermann-Ramos A, Koehler B (2000). "Congenital adrenal hyperplasia conditioned by 21beta-hydroxylase deficiency - clinical considerations". Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego (in Polish). 6 (1): 67–9. PMID 14640134.
10. ^  This article incorporates public domain material from "NCBI: CYP21A2 cytochrome P450 family 21 subfamily A member 2". Reference Sequence collection. National Center for Biotechnology Information. Retrieved 30 November 2020. This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene.
11. Ryan KJ, Engel LL (March 1957). "Hydroxylation of steroids at carbon 21" (PDF). The Journal of Biological Chemistry. 225 (1): 103–14. doi:10.1016/S0021-9258(18)64913-0. PMID 13416221. Archived (PDF) from the original on 25 March 2020. Retrieved 17 October 2009.
12. ^ Pallan PS, Wang C, Lei L, Yoshimoto FK, Auchus RJ, Waterman MR, Guengerich FP, Egli M (May 2015). "Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: structure of the enzyme progesterone substrate complex and rate-limiting c-h bond cleavage". The Journal of Biological Chemistry. 290 (21): 13128–43. doi:10.1074/jbc.M115.646307. PMC 4505568. PMID 25855791.
13. ^ Neunzig J, Milhim M, Schiffer L, Khatri Y, Zapp J, Sánchez-Guijo A, et al. (March 2017). "The steroid metabolite 16(β)-OH-androstenedione generated by CYP21A2 serves as a substrate for CYP19A1". The Journal of Steroid Biochemistry and Molecular Biology. 167: 182–191. doi:10.1016/j.jsbmb.2017.01.002. PMID 28065637. S2CID 36860068.
14. ^ Guengerich FP, Waterman MR, Egli M (August 2016). "Recent Structural Insights into Cytochrome P450 Function". Trends in Pharmacological Sciences. 37 (8): 625–40. doi:10.1016/j.tips.2016.05.006. PMC 4961565. PMID 27267697.
15. Sushko TA, Gilep AA, Usanov SA (June 2012). "Mechanism of intermolecular interactions of microsomal cytochrome P450s CYP17 and CYP21 involved in steroid hormone biosynthesis". Biochemistry. Biokhimiia. 77 (6): 585–92. doi:10.1134/S0006297912060041. PMID 22817457. S2CID 18927484.
16. ^ ENSG00000231852, ENSG00000206338, ENSG00000233151, ENSG00000232414, ENSG00000235134 GRCh38: Ensembl release 89: ENSG00000198457, ENSG00000231852, ENSG00000206338, ENSG00000233151, ENSG00000232414, ENSG00000235134 – Ensembl, May 2017
17. ^ GRCm38: Ensembl release 89: ENSMUSG00000024365 – Ensembl, May 2017
18. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
19. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
20.  This article incorporates public domain material from "CYP21A2 cytochrome P450 family 21 subfamily A member 2 [ Homo sapiens (human) ]". Reference Sequence collection. National Center for Biotechnology Information.
21. Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W (October 2020). "EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency". European Journal of Human Genetics. 28 (10): 1341–1367. doi:10.1038/s41431-020-0653-5. PMC 7609334. PMID 32616876. S2CID 220295067.
22. Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y (May 1986). "Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene". Proceedings of the National Academy of Sciences of the United States of America. 83 (9): 2841–5. Bibcode:1986PNAS...83.2841H. doi:10.1073/pnas.83.9.2841. PMC 323402. PMID 3486422.
23. Concolino P, Rizza R, Costella A, Carrozza C, Zuppi C, Capoluongo E (June 2017). "CYP21A2 intronic variants causing 21-hydroxylase deficiency". Metabolism: Clinical and Experimental. 71: 46–51. doi:10.1016/j.metabol.2017.03.003. PMID 28521877.
24. Witek J, Mohiuddin SS (2023). Biochemistry, Pseudogenes. Treasure Island (FL): StatPearls Publishing. PMID 31751022. NCBI NBK549832.
25. ^ Parker KL, Chaplin DD, Wong M, Seidman JG, Smith JA, Schimmer BP (December 1985). "Expression of murine 21-hydroxylase in mouse adrenal glands and in transfected Y1 adrenocortical tumor cells". Proceedings of the National Academy of Sciences of the United States of America. 82 (23): 7860–4. Bibcode:1985PNAS...82.7860P. doi:10.1073/pnas.82.23.7860. PMC 390869. PMID 2999780.
26. Shiina T, Shimizu S, Hosomichi K, Kohara S, Watanabe S, Hanzawa K, et al. (June 2004). "Comparative genomic analysis of two avian (quail and chicken) MHC regions". Journal of Immunology. 172 (11): 6751–63. doi:10.4049/jimmunol.172.11.6751. PMID 15153492.
27. ^ Yu CY (1999). "Molecular genetics of the human MHC complement gene cluster". Experimental and Clinical Immunogenetics. 15 (4): 213–230. doi:10.1159/000019075. PMID 10072631. S2CID 25061446.
28. White PC, Grossberger D, Onufer BJ, Chaplin DD, New MI, Dupont B, Strominger JL (February 1985). "Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man". Proceedings of the National Academy of Sciences of the United States of America. 82 (4): 1089–1093. Bibcode:1985PNAS...82.1089W. doi:10.1073/pnas.82.4.1089. PMC 397199. PMID 2983330.
29. Xie T, Rowen L, Aguado B, Ahearn ME, Madan A, Qin S, et al. (December 2003). "Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse". Genome Research. 13 (12): 2621–2636. doi:10.1101/gr.1736803. PMC 403804. PMID 14656967.
30. ^ Bánlaki Z, Doleschall M, Rajczy K, Fust G, Szilágyi A (October 2012). "Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes". Genes and Immunity. 13 (7): 530–535. doi:10.1038/gene.2012.29. PMID 22785613. S2CID 36582994.
31. ^ Carrozza C, Foca L, De Paolis E, Concolino P (2021). "Genes and Pseudogenes: Complexity of the RCCX Locus and Disease". Frontiers in Endocrinology. 12: 709758. doi:10.3389/fendo.2021.709758. PMC 8362596. PMID 34394006.
32. Sweeten TL, Odell DW, Odell JD, Torres AR (January 2008). "C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism". BMC Medical Genetics. 9: 1. doi:10.1186/1471-2350-9-1. PMC 2265260. PMID 18179706.
33. Milner CM, Campbell RD (August 2001). "Genetic organization of the human MHC class III region". Frontiers in Bioscience. 6: D914–D926. doi:10.2741/milner. PMID 11487476.
34. Kim JH, Kim GH, Yoo HW, Choi JH (June 2023). "Molecular basis and genetic testing strategies for diagnosing 21-hydroxylase deficiency, including CAH-X syndrome". Annals of Pediatric Endocrinology & Metabolism. 28 (2): 77–86. doi:10.6065/apem.2346108.054. PMC 10329939. PMID 37401054.
35. ^ Bánlaki Z, Szabó JA, Szilágyi Á, Patócs A, Prohászka Z, Füst G, Doleschall M (2013). "Intraspecific evolution of human RCCX copy number variation traced by haplotypes of the CYP21A2 gene". Genome Biol Evol. 5 (1): 98–112. doi:10.1093/gbe/evs121. PMC 3595039. PMID 23241443.
36. Tsai LP, Lee HH (September 2012). "Analysis of CYP21A1P and the duplicated CYP21A2 genes". Gene. 506 (1): 261–262. doi:10.1016/j.gene.2012.06.045. PMID 22771554.
37. ^ Arriba M, Ezquieta B (2022). "Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach". Front Endocrinol. 13: 834549. doi:10.3389/fendo.2022.834549. PMC 9001848. PMID 35422767.
38. ^ Karaoğlan M, Nacarkahya G, Aytaç EH, Keskin M (November 2021). "Challenges of CYP21A2 genotyping in children with 21-hydroxylase deficiency: determination of genotype-phenotype correlation using next generation sequencing in Southeastern Anatolia". J Endocrinol Invest. 44 (11): 2395–2405. doi:10.1007/s40618-021-01546-z. PMID 33677812. S2CID 232133292.
39. Xu Z, Chen W, Merke DP, McDonnell NB (November 2013). "Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia". J Mol Diagn. 15 (6): 745–53. doi:10.1016/j.jmoldx.2013.06.001. PMC 5803549. PMID 24071710.
40. "Polymerase Chain Reaction (PCR) Fact Sheet". Genome.gov. Archived from the original on 3 December 2023. Retrieved 3 December 2023.
41. "Southern blotting — Knowledge Hub". GeNotes. Archived from the original on 3 December 2023. Retrieved 3 December 2023.
42. Guo X, Zhang Y, Yu Y, Zhang L, Ullah K, Ji M, Jin B, Shu J (2023). "Corrigendum: Getting pregnant with congenital adrenal hyperplasia: assisted reproduction and pregnancy complications. A systematic review and meta-analysis". Front Endocrinol. 14: 1269711. doi:10.3389/fendo.2023.1269711. PMC 10575760. PMID 37842302.
43. Adachi E, Nakagawa R, Tsuji-Hosokawa A, Gau M, Kirino S, Yogi A, Nakatani H, Takasawa K, Yamaguchi T, Kosho T, Murakami M, Tajima T, Hasegawa T, Yamada T, Morio T, Ohara O, Kashimada K (October 2023). "A MinION-Based Long-Read Sequencing Application with One-Step PCR for the Genetic Diagnosis of 21-Hydroxylase Deficiency". J Clin Endocrinol Metab. 109 (3): 750–760. doi:10.1210/clinem/dgad577. PMID 37804107. S2CID 263742489.
44. Zhang X, Gao Y, Lu L, Cao Y, Zhang W, Sun B, Wu X, Tong A, Chen S, Wang X, Mao J, Nie M (2023). "Targeted long-read sequencing for comprehensive detection of CYP21A2 mutations in patients with 21-hydroxylase deficiency". Journal of Endocrinological Investigation. 47 (4): 833–841. doi:10.1007/s40618-023-02197-y. PMID 37815751. S2CID 263800944.
45. "Steroid 21-hydroxylase | DrugBank Online". go.drugbank.com. Archived from the original on 28 November 2023. Retrieved 27 November 2023.
46. Werck-Reichhart D, Feyereisen R (2000). "Cytochromes P450: a success story". Genome Biology. 1 (6): REVIEWS3003. doi:10.1186/gb-2000-1-6-reviews3003. PMC 138896. PMID 11178272.
47. Zhao B, Lei L, Kagawa N, Sundaramoorthy M, Banerjee S, Nagy LD, Guengerich FP, Waterman MR (March 2012). "Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants". The Journal of Biological Chemistry. 287 (13): 10613–22. doi:10.1074/jbc.M111.323501. PMC 3323056. PMID 22262854.
48. ^ Graham SE, Peterson JA (2002). "Sequence alignments, variabilities, and vagaries". Cytochrome P450 Part C. Methods in Enzymology. Vol. 357. Academic Press. pp. 15–28. doi:10.1016/s0076-6879(02)57661-8. ISBN 978-0-12-182260-6. PMID 12424893.
49. Baker ME, Nelson DR, Studer RA (July 2015). "Origin of the response to adrenal and sex steroids: Roles of promiscuity and co-evolution of enzymes and steroid receptors". J Steroid Biochem Mol Biol. 151: 12–24. doi:10.1016/j.jsbmb.2014.10.020. PMID 25445914. S2CID 21649057.
50. Barany A, Shaughnessy CA, McCormick SD (March 2021). "Corticosteroid control of Na+/K+-ATPase in the intestine of the sea lamprey (Petromyzon marinus)". General and Comparative Endocrinology. 307: 113756. doi:10.1016/j.ygcen.2021.113756. PMID 33741310. S2CID 232296805.
51. ^ Cameron PU, Tabarias HA, Pulendran B, Robinson W, Dawkins RL (1990). "Conservation of the central MHC genome: PFGE mapping and RFLP analysis of complement, HSP70, and TNF genes in the goat". Immunogenetics. 31 (4): 253–64. doi:10.1007/BF00204897. PMID 1970334. S2CID 22716959.
52. Kawashima A, Satta Y (2014). "Substrate-dependent evolution of cytochrome P450: rapid turnover of the detoxification-type and conservation of the biosynthesis-type". PLOS ONE. 9 (6): e100059. Bibcode:2014PLoSO...9j0059K. doi:10.1371/journal.pone.0100059. PMC 4076195. PMID 24977709.
53. Auchus RJ, Miller WL (2015). "P450 Enzymes in Steroid Processing". Cytochrome P450: Structure, Mechanism, and Biochemistry (Fourth ed.). Springer International Publishing. pp. 851–879. doi:10.1007/978-3-319-12108-6_12. ISBN 978-3-319-12107-9.
54. Korzekwa K (2014). "Enzyme Kinetics of Oxidative Metabolism: Cytochromes P450". Enzyme Kinetics in Drug Metabolism. Methods in Molecular Biology. Vol. 1113. Humana Press. pp. 149–166. doi:10.1007/978-1-62703-758-7_8. ISBN 978-1-62703-757-0. ISSN 1940-6029. PMID 24523112.
55. "Tissue expression of CYP21A2". The Human Protein Atlas. Archived from the original on 28 November 2023. Retrieved 27 November 2023.
56. "CYP21A2 Subcellular RNA expression". The Human Protein Atlas. Archived from the original on 28 November 2023. Retrieved 27 November 2023.
57. Araújo RS, Mendonca BB, Barbosa AS, Lin CJ, Marcondes JA, Billerbeck AE, Bachega TA (October 2007). "Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency". The Journal of Clinical Endocrinology and Metabolism. 92 (10): 4028–34. doi:10.1210/jc.2006-2163. PMID 17666484.
58. ^ Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. (November 2018). "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline". The Journal of Clinical Endocrinology and Metabolism. 103 (11): 4043–4088. doi:10.1210/jc.2018-01865. PMC 6456929. PMID 30272171.
59. ^ Auchus RJ, Sampath Kumar A, Andrew Boswell C, Gupta MK, Bruce K, Rath NP, Covey DF (January 2003). "The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 and P450c21". Archives of Biochemistry and Biophysics. 409 (1): 134–44. doi:10.1016/s0003-9861(02)00491-5. PMID 12464252.
60. Rosenfeld G, Ungar F, Dorfman RI, Pincus G (1955). "Irradiation and adrenal steroidogenesis: steroid transformations by irradiated isolated perfused calf adrenals". Endocrinology. 56 (1): 24–9. doi:10.1210/endo-56-1-24. PMID 13220521.
61. Dorfman RI, Hayano M (March 1952). "The action of adrenal homogenates on progesterone, 17-hydroxyprogesterone and 21-desoxycortisone". Archives of Biochemistry and Biophysics. 36 (1): 237–9. doi:10.1016/0003-9861(52)90397-4. PMID 14934270.
62. Lorence MC, Trant JM, Mason JI, Bhasker CR, Fujii-Kuriyama Y, Estabrook RW, Waterman MR (August 1989). "Expression of a full-length cDNA encoding bovine adrenal cytochrome P450C21". Archives of Biochemistry and Biophysics. 273 (1): 79–88. doi:10.1016/0003-9861(89)90164-1. PMID 2502949.
63. Wu DA, Hu MC, Chung BC (April 1991). "Expression and functional study of wild-type and mutant human cytochrome P450c21 in Saccharomyces cerevisiae". DNA and Cell Biology. 10 (3): 201–9. doi:10.1089/dna.1991.10.201. PMID 1707279.
64. "NCBI: CYP21A2 cytochrome P450 family 21 subfamily A member 2". National Center for Biotechnology Information. Archived from the original on 28 October 2020. Retrieved 30 November 2020. This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. This article incorporates text from this source, which is in the public domain.
65. ^ Merke DP, Auchus RJ (September 2020). "Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency". The New England Journal of Medicine. 383 (13): 1248–1261. doi:10.1056/NEJMra1909786. PMID 32966723. S2CID 221884108.
66. ^ Miller WL, Auchus RJ (February 2011). "The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders". Endocrine Reviews. 32 (1): 81–151. doi:10.1210/er.2010-0013. PMC 3365799. PMID 21051590.
67. Sharquie KE, Noaimi AA, Saleh BO, Anbar ZN (December 2009). "The frequency of 21-alpha hydroxylase enzyme deficiency and related sex hormones in Iraqi healthy male subjects versus patients with acne vulgaris". Saudi Medical Journal. 30 (12): 1547–50. PMID 19936418.
68. Falhammar H, Nordenström A (September 2015). "Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome". Endocrine. 50 (1): 32–50. doi:10.1007/s12020-015-0656-0. PMID 26082286. S2CID 23469344.
69. New MI (November 2006). "Extensive clinical experience: nonclassical 21-hydroxylase deficiency". The Journal of Clinical Endocrinology and Metabolism. 91 (11): 4205–14. doi:10.1210/jc.2006-1645. PMID 16912124. Loss of scalp hair in females and males is embarrassing, requiring treatment with 5α-reductase inhibitors
70. Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, Grossman A, Hershman JM, Hofland J, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Purnell J, Singer F, Stratakis CA, Trence DL, Wilson DP, Yau M, Gujral J, New MI (April 2019). Congenital Adrenal Hyperplasia: Diagnosis and Emergency Treatment. MDText.com. PMID 25905311. Archived from the original on 14 November 2020. Retrieved 25 March 2021.
71. Witchel SF, Azziz R (2010). "Nonclassic congenital adrenal hyperplasia". International Journal of Pediatric Endocrinology. 2010: 625105. doi:10.1155/2010/625105. PMC 2910408. PMID 20671993.
72. Berry V, Pontikos N, Ionides A, Kalitzeos A, Quinlan RA, Michaelides M (April 2022). "Pathogenic variants in the CYP21A2 gene cause isolated autosomal dominant congenital posterior polar cataracts". Ophthalmic Genet. 43 (2): 218–223. doi:10.1080/13816810.2021.1998556. PMID 34748434. S2CID 243861798. Archived from the original on 2 February 2024. Retrieved 2 February 2024.
73. ^ Miller WL, White PC (January 2023). "History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology". Endocr Rev. 44 (1): 70–116. doi:10.1210/endrev/bnac019. PMC 9835964. PMID 35947694.
74. Yamazaki H, ed. (2014). Fifty Years of Cytochrome P450 Research. doi:10.1007/978-4-431-54992-5. ISBN 978-4-431-54991-8. S2CID 27237884.
75. Miller WL (2020). "Tenascin-X-Discovery and Early Research". Front Immunol. 11: 612497. doi:10.3389/fimmu.2020.612497. PMC 7829301. PMID 33505400.

External links

• GeneReviews/NCBI/NIH/UW entry on 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia Archived 31 May 2010 at the Wayback Machine
• OMIM entry on 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia Archived 29 June 2011 at the Wayback Machine
• Synthesis of Desoxycorticosterone from Progesterone through 21-Hydroxylase (Image) Archived 26 April 2021 at the Wayback Machine
• Steroid+21-Hydroxylase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
• Human CPS1 genome location and CPS1 gene details page in the UCSC Genome Browser.
• Human CYP21A2 genome location and CYP21A2 gene details page in the UCSC Genome Browser.
• Overview of all the structural information available in the PDB for UniProt: P08686 (Steroid 21-hydroxylase) at the PDBe-KB.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

• Genes on human chromosome 6
• Enzymes
• EC 1.14.99
• Cytochrome P450
• Metabolism
• Human proteins
• Steroid hormone biosynthesis